IP Library Granted Patent US 7,638,276
Granted Patent B2
US 7,638,276 · App. 10/861,930 · Granted Dec 29, 2009

In vitro sorting method

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,638,276
App. No.
10/861,930
Granted
Dec 29, 2009
Kind
B2
Abstract

The invention describes a method for isolating one or more genetic elements encoding a gene product having a desired activity, comprising of the steps of: (a) compartmentalising genetic elements into microcapsules; (b) expressing the genetic elements to produce their respective gene products within the microcapsules; (c) sorting the genetic elements which produce the gene product having a desired activity. The invention enables the in vitro evolution of nucleic acids by repeated mutagenesis and iterative applications of the method of the invention.

Claims (14)

1. A method for increasing the concentration of a nucleic acid molecule by polymerase chain reaction amplification comprising the steps of:

(a) forming aqueous microcapsules from a thermostable water-in-oil emulsion, wherein a plurality of the microcapsules include a nucleic acid molecule, a bead, and an aqueous solution comprising components necessary for polymerase chain reaction amplification;

(b) amplifying the nucleic acid molecule in the microcapsules to form amplified copies of the nucleic acid molecule which bind to said bead; and

(c) breaking the microcapsules and selecting for said amplified copies of the nucleic acid molecule using a tag, wherein the tag comprises one member of a binding pair.

2. The method of claim 1 wherein the emulsion includes at least one emulsion stabilizer.

3. The method of claim 2 wherein the emulsion stabilizer is a non-ionic surfactant.

4. The method of claim 3 wherein the emulsion stabilizer is selected from the group consisting of sorbitan monooleate and polyoxyethylenesorbitan monooleate.

5. The method of claim 2 wherein the emulsion stabilizer is an anionic surfactant.

6. The method of claim 5 wherein the emulsion stabilizer is selected from the group consisting of sodium cholate, sodium glycocholate, sodium taurocholate, and sodium deoxycholate.

7. The method of claim 1 wherein the nucleic acid molecule comprises a biotin tag.

8. The method of claim 1 wherein the bead is selected from the group consisting of polystyrene and magnetic beads.

9. The method of claim 1 wherein a plurality of microcapsules when formed contains on average one or less than one nucleic acid molecule per microcapsule.

10. The method of claim 1 wherein a plurality of microcapsules when formed each contains on average between 5 and 1000 nucleic acid molecules.

11. The method of claim 1 wherein the binding pair is biotin -avidin/streptavidin.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 2, 2018
From: MEDICAL RESEARCH COUNCIL
To: UNITED KINGDOM RESEARCH AND INNOVATION
Reel/Frame 046469/0108 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 27, 2009
From: GRIFFITHS, ANDREW; TAWFIK, DAN
To: MEDICAL RESEARCH COUNCIL
Reel/Frame 022461/0506 →